谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase II Study of Anlotinib with Cediranib As a Second-Line Treatment for Patients with Advanced Biliary Tract Cancers (Abtcs).

Ruihua Zhao,Hong Zong,Shuiling Jin,Qian Zhong,Miao Jiang, Ming Jin,Rui Li,Guozhong Jiang

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 2|浏览31
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要